Structure and function of the mammalian fibrillin gene family: Implications for human connective tissue diseases

• Published in: Molecular genetics and metabolism 2012-12, Vol.107 (4), p.635-647
• Main Authors: Davis, Margaret R., Summers, Kim M.
• Format: Article
• Language: English
• Subjects: Aneurysm; Animals; Arachnodactyly; Calcium; Congenital contractural arachnodactyly; Connective tissue; Connective tissue diseases; Connective Tissue Diseases - genetics; Connective Tissue Diseases - metabolism; Connective tissues; Cysteine; Elastin; Extracellular matrix; Fetuses; Fibrillin; Fibrillin-1; Fibrillin-2; Fibrillins; Glycoproteins; Humans; Latent TGF-beta Binding Proteins - genetics; Latent TGF-beta Binding Proteins - metabolism; Latent transforming growth factor β binding protein; Marfan syndrome; Marfan's syndrome; Mesenchyme; Microfibrils; Microfilament Proteins - genetics; Microfilament Proteins - metabolism; Monomers; Multigene Family; Mutation; Structure-function relationships; Thorax; Transforming growth factor β bioavailability; Transforming growth factor- beta
• ISSN: 1096-7192; 1096-7206
• DOI: 10.1016/j.ymgme.2012.07.023

Fibrillins and latent transforming growth factor β binding proteins (LTBPs) are components of the extracellular matrix of connective tissue. While fibrillins are integral to the 10nm microfibrils, and often associated with elastin, all family members are likely to have an additional role in regulating the bioavailability of transforming growth factor β (TGBβ). Both fibrillins and LTBPs are large glycoproteins, containing a series of calcium binding epidermal growth factor domains as well as a number of copies of a unique 8 cysteine domain found only in this protein superfamily. There are three mammalian fibrillins and four LTBPs. Fibrillin monomers link head to tail in microfibrils which can then form two and three dimensional structures. In some tissues elastin is recruited to the fibrillin microfibrils to provide elasticity to the tissue. LTBPs are part of the TGBβ large latent complex which sequesters TGBβ in the extracellular matrix. Fibrillin-1 appears to bind to LTBPs to assist in this process and is thus involved in regulating the bioavailability of TGBβ. Mutation of fibrillin genes results in connective tissue phenotypes which reflect both the increased level of active TGBβ and the structural failure of the extracellular matrix due to the absence or abnormality of fibrillin protein. Fibrillinopathies include Marfan syndrome, familial ectopia lentis, familial thoracic aneurysm (mutations of FBN1) and congenital contractural arachnodactyly (mutation of FBN2). There are no diseases currently associated with mutation of FBN3 in humans, and this gene is no longer active in rodents. Expression patterns of fibrillin genes are consistent with their role in extracellular matrix structure of connective tissue. FBN1 expression is high in most cell types of mesenchymal origin, particularly bone. Human and mouse FBN2 expression is high in fetal cells and has more restricted expression in mesenchymal cell types postnatally. FBN3 is expressed early in development (embryonic and fetal tissues) in humans. The fibrillins are thus important in maintaining the structure and integrity of the extracellular matrix and, in combination with their sequence family members the LTBPs, also contribute to the regulation of the TGFβ family of major growth factors. ► Fibrillins and LTBPs form a unique family of extracellular matrix proteins. ► Fibrillins and LTBPs are expressed in connective tissues with differing specificity. ► Fibrillins form 10nm microfibrils which support conn